Rafferty Asset Management, LLC Inovio Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.79 - $1.91 $248,996 - $602,003	-315,185 Reduced 10.64%	2,647,927 $2.17 Million
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $845,891 - $1.5 Million	599,923 Added 25.39%	2,963,112 $4.62 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $483,700 - $812,966	291,386 Added 14.06%	2,363,189 $4.08 Million
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $132,448 - $366,072	91,978 Added 4.65%	2,071,803 $3.58 Million
Q1 2022 May 13, 2022	BUY	$2.97 - $5.2 $2.22 Million - $3.89 Million	747,754 Added 60.69%	1,979,825 $7.11 Million
Q4 2021 Feb 10, 2022	BUY	$4.99 - $7.46 $2.41 Million - $3.61 Million	483,416 Added 64.57%	1,232,071 $6.15 Million
Q3 2021 Nov 10, 2021	BUY	$7.16 - $9.69 $606,502 - $820,810	84,707 Added 12.76%	748,655 $5.36 Million
Q2 2021 Aug 10, 2021	SELL	$6.23 - $10.03 $170,278 - $274,139	-27,332 Reduced 3.95%	663,948 $6.16 Million
Q1 2021 May 10, 2021	BUY	$8.81 - $16.96 $4.87 Million - $9.38 Million	553,005 Added 399.93%	691,280 $6.42 Million
Q4 2020 Feb 10, 2021	SELL	$8.5 - $12.85 $497,819 - $752,585	-58,567 Reduced 29.75%	138,275 $1.22 Million
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $1.18 Million - $3.34 Million	123,495 Added 168.37%	196,842 $2.28 Million
Q2 2020 Aug 07, 2020	BUY	$7.14 - $31.69 $523,697 - $2.32 Million	73,347 New	73,347 $1.98 Million
Q2 2019 Aug 09, 2019	SELL	$2.29 - $4.1 $431,795 - $773,083	-188,557 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.34 - $5.1 $629,780 - $961,640	188,557 New	188,557 $703,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.